Tolcapone Improves Cognition and Cortical Information Processing in Normal Human Subjects
- 25 October 2006
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 32 (5) , 1011-1020
- https://doi.org/10.1038/sj.npp.1301227
Abstract
Prefrontal cortical dopamine (DA) regulates various executive cognitive functions, including attention and working memory. Efforts to enhance prefrontal-related cognition, which have focused on catecholaminergic stimulant drugs, have been unsatisfactory. Recently, the demonstration that a functional polymorphism in the catecholamine-O-methyltransferase (COMT) gene impacts prefrontal cognition raises the possibility of a novel pharmacological approach for the treatment of prefrontal lobe executive dysfunction. To explore in a proof of concept study the effects of tolcapone, a CNS penetrant specific COMT inhibitor, we performed a randomized, double blind, placebo controlled, and crossover design of this drug in normal subjects stratified by COMT (val158met) genotype. COMT enzyme activity was determined in peripheral blood. Forty-seven normal volunteers with no family history of psychiatric disorders underwent neuropsychological testing and 34 of those subjects underwent physiological measurement of prefrontal information processing assessed by blood oxygen level-dependent functional magnetic resonance imaging (fMRI). We found significant drug effects on measures of executive function and verbal episodic memory and a significant drug by genotype interaction on the latter, such that individuals with val/val genotypes improved, whereas individuals with met/met genotypes worsened on tolcapone. fMRI revealed a significant tolcapone-induced improvement in the efficiency of information processing in prefrontal cortex during a working memory test. This study demonstrates enhancement of prefrontal cortical function in normal human subjects with a nonstimulant drug having COMT inhibitory activity. Our results are consistent with data from animal studies and from computational models of the effects of selective enhancement of DA signaling in the prefrontal cortex.Keywords
This publication has 32 references indexed in Scilit:
- Functional Analysis of Genetic Variation in Catechol-O-Methyltransferase (COMT): Effects on mRNA, Protein, and Enzyme Activity in Postmortem Human BrainAmerican Journal of Human Genetics, 2004
- COMT Gene Polymorphism Is Associated with Declarative Memory in Adulthood and Old AgeBehavior Genetics, 2004
- Pharmacokinetics and Pharmacodynamics of Entacapone and Tolcapone after Acute and Repeated Administration: A Comparative Study in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PETBrain, 2002
- 18F‐dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's diseaseSynapse, 2001
- Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophreniaProceedings of the National Academy of Sciences, 2001
- Prefrontal cortical contributions to working memory: evidence from event-related fMRI studiesExperimental Brain Research, 2000
- Catechol- O -methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behaviorProceedings of the National Academy of Sciences, 1998
- Cognitive improvement during Tolcapone treatment in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Auditory Working Memory and Wisconsin Card Sorting Test Performance in SchizophreniaArchives of General Psychiatry, 1997